Sofinnova Investments’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1M | Hold |
4,280,308
| – | – | 1.05% | 26 |
|
|
2025
Q1 | $3.9M | Hold |
4,280,308
| – | – | 0.25% | 48 |
|
|
2024
Q4 | $11.9M | Hold |
4,280,308
| – | – | 0.86% | 29 |
|
|
2024
Q3 | $22.4M | Hold |
4,280,308
| – | – | 1.78% | 17 |
|
|
2024
Q2 | $19.1M | Hold |
4,280,308
| – | – | 0.99% | 28 |
|
|
2024
Q1 | $32.8M | Hold |
4,280,308
| – | – | 1.83% | 20 |
|
|
2023
Q4 | $18.2M | Hold |
4,280,308
| – | – | 1.02% | 26 |
|
|
2023
Q3 | $18M | Buy |
4,280,308
+625,000
| +17% | +$2.63M | 1.13% | 22 |
|
|
2023
Q2 | $20.4M | Hold |
3,655,308
| – | – | 1.33% | 20 |
|
|
2023
Q1 | $20.9M | Hold |
3,655,308
| – | – | 1.34% | 22 |
|
|
2022
Q4 | $3.84M | Hold |
3,655,308
| – | – | 0.23% | 37 |
|
|
2022
Q3 | $9.8M | Hold |
3,655,308
| – | – | 0.57% | 28 |
|
|
2022
Q2 | $17.4M | Buy |
3,655,308
+1,627,000
| +80% | +$7.76M | 1.45% | 16 |
|
|
2022
Q1 | $8.3M | Hold |
2,028,308
| – | – | 0.63% | 31 |
|
|
2021
Q4 | $13.8M | Hold |
2,028,308
| – | – | 0.81% | 28 |
|
|
2021
Q3 | $23.5M | Hold |
2,028,308
| – | – | 1.39% | 14 |
|
|
2021
Q2 | $34.6M | Hold |
2,028,308
| – | – | 1.99% | 11 |
|
|
2021
Q1 | $40.2M | Hold |
2,028,308
| – | – | 2.41% | 9 |
|
|
2020
Q4 | $41.9M | Hold |
2,028,308
| – | – | 2.49% | 8 |
|
|
2020
Q3 | $53.3M | Buy |
+2,028,308
| New | +$53.3M | 3.95% | 5 |
|